{
    "2020-05-10": [
        [
            {
                "time": "",
                "original_text": "下周操盘策略：4月CPI工业增加值等重磅数据即将发布",
                "features": {
                    "keywords": [
                        "CPI",
                        "工业增加值",
                        "重磅数据"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "宏观经济"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "[路演]智飞生物总经理蒲江：宜卡(R) 走向国际",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "宜卡",
                        "国际"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "[路演]智飞生物宜卡(R) 上市 填补国内结核病诊断空白",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "宜卡",
                        "结核病",
                        "诊断",
                        "填补空白"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "[路演]方向民：智飞生物结核病防治矩阵已实现中国“智”造",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "结核病",
                        "防治矩阵",
                        "中国制造"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物一类新药宜卡上市 全球结核防治迎新诊断利器",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "宜卡",
                        "新药",
                        "全球",
                        "结核病",
                        "诊断"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "我国和全球结核病防治迎来新型诊断工具 智飞生物1类新药宜卡正式上市",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "宜卡",
                        "结核病",
                        "新型诊断工具",
                        "全球"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物董事长蒋仁生：宜卡可解决传统无法鉴别卡介苗接种与结核感染困境",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "宜卡",
                        "卡介苗",
                        "结核感染",
                        "困境"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物构建结核病防治矩阵，已有2款上市产品及4款在研产品",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "结核病",
                        "防治矩阵",
                        "上市产品",
                        "在研产品"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：宜卡使用不受实验室条件限制 可实现年产3000万人份生产规模",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "宜卡",
                        "实验室条件",
                        "生产规模"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物自研重磅新药宜卡上市，全球首款结核病诊断生物制品",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "宜卡",
                        "自研",
                        "重磅新药",
                        "全球首款",
                        "结核病",
                        "诊断"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【e公司直播】智飞生物重组结核杆菌融合蛋白（EC，宜卡）新闻发布会",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "重组结核杆菌融合蛋白",
                        "EC",
                        "宜卡",
                        "新闻发布会"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}